Hideo Yagita Selected Research

Hideo Yagita Research Topics

Disease

150	Neoplasms (Cancer) 10/2022 - 01/2002
31	Inflammation (Inflammations) 01/2021 - 01/2004
24	Infections 01/2017 - 06/2003
20	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2002
15	Colitis 01/2021 - 02/2003
15	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 07/2002
14	Melanoma (Melanoma, Malignant) 11/2021 - 04/2008
14	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2005
13	Necrosis 10/2018 - 01/2002
12	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2016 - 07/2002
9	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 11/2014 - 10/2004
8	Reperfusion Injury 01/2021 - 08/2008
8	Asthma (Bronchial Asthma) 01/2017 - 04/2003
7	Atherosclerosis 01/2019 - 01/2007
7	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2019 - 07/2003
6	Ischemia 01/2021 - 08/2008
6	Leukemia 01/2021 - 05/2003
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019 - 05/2002
6	Lymphoma (Lymphomas) 01/2016 - 10/2002
6	Eosinophilia 07/2011 - 07/2003
5	Hypersensitivity (Allergy) 10/2022 - 07/2003
5	Arthritis (Polyarthritis) 01/2018 - 10/2002
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2015 - 10/2003
5	Experimental Arthritis 11/2014 - 10/2002
5	Contact Dermatitis (Eczema, Contact) 11/2014 - 10/2003
5	Multiple Sclerosis 03/2014 - 03/2010
5	Fibrosis (Cirrhosis) 01/2013 - 05/2004
5	Chagas Disease (American Trypanosomiasis) 04/2007 - 04/2002
4	Glomerulonephritis 01/2021 - 02/2006
4	Carcinoma (Carcinomatosis) 12/2020 - 09/2004
4	Sepsis (Septicemia) 01/2020 - 09/2009
4	Colonic Neoplasms (Colon Cancer) 01/2020 - 09/2004
4	Rheumatoid Arthritis 01/2018 - 10/2002
4	Lupus Nephritis 05/2014 - 03/2002
4	Demyelinating Diseases (Demyelinating Disease) 03/2014 - 03/2010
4	Carcinogenesis 01/2014 - 04/2009
4	Hepatitis 01/2013 - 10/2004
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2011 - 04/2007
3	Esophageal Neoplasms (Esophageal Cancer) 11/2021 - 04/2005
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 10/2010

Drug/Important Bio-Agent (IBA)

72	LigandsIBA 01/2021 - 01/2002
47	Monoclonal AntibodiesIBA 01/2022 - 01/2002
45	CytokinesIBA 01/2021 - 02/2002
45	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2002
34	AntigensIBA 01/2022 - 05/2002
26	AntibodiesIBA 01/2021 - 01/2003
19	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2002
16	TNF-Related Apoptosis-Inducing LigandIBA 01/2021 - 02/2002
15	Fas Ligand Protein (Fas Ligand)IBA 01/2017 - 02/2002
13	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 11/2013 - 02/2004
12	VaccinesIBA 01/2021 - 08/2008
12	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 06/2003
11	Interleukin-10 (Interleukin 10)IBA 01/2020 - 10/2003
10	Therapeutic UsesIBA 01/2022 - 09/2003
9	PerforinIBA 01/2018 - 01/2002
9	Interleukin-2 (IL2)IBA 01/2017 - 10/2003
9	Messenger RNA (mRNA)IBA 04/2016 - 03/2002
9	Immunoglobulins (Immunoglobulin)IBA 05/2014 - 04/2010
8	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2017
8	Death Domain ReceptorsIBA 01/2021 - 01/2003
8	InterferonsIBA 10/2019 - 01/2002
8	Peptides (Polypeptides)IBA 01/2019 - 12/2004
8	Immunoglobulin G (IgG)IBA 10/2017 - 10/2002
7	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 12/2004
7	NF-kappa B (NF-kB)IBA 01/2020 - 09/2003
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 11/2009
7	Neutralizing AntibodiesIBA 10/2017 - 10/2004
7	alpha-galactosylceramideIBA 08/2007 - 02/2002
6	EpitopesIBA 01/2017 - 10/2004
6	MucinsIBA 12/2013 - 02/2007
6	Interleukin-4 (Interleukin 4)IBA 03/2013 - 02/2002
6	Interferon-gamma (Interferon, gamma)IBA 02/2012 - 01/2002
5	AllergensIBA 01/2021 - 04/2003
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2013
5	ChemokinesIBA 10/2020 - 01/2011
5	Pharmaceutical PreparationsIBA 01/2020 - 03/2003
5	Immunoglobulin E (IgE)IBA 03/2017 - 10/2003
5	Interleukin-12 (IL 12)IBA 11/2016 - 02/2002
5	B7-H1 AntigenIBA 04/2016 - 03/2006
5	CaspasesIBA 01/2016 - 01/2002
5	TWEAK ReceptorIBA 07/2013 - 01/2002
5	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 04/2013 - 09/2003
5	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2012 - 07/2007
4	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 03/2009
4	InterleukinsIBA 01/2021 - 05/2007
4	Programmed Cell Death 1 ReceptorIBA 01/2020 - 02/2006
4	EnzymesIBA 01/2019 - 01/2003
4	IntegrinsIBA 01/2019 - 09/2013
4	interleukin-21 (interleukin 21)IBA 11/2014 - 06/2005
4	OvalbuminIBA 11/2014 - 04/2003
4	Mucin-1 (CA 15-3 Antigen)IBA 05/2014 - 02/2008
4	Interleukin-18 (Interleukin 18)IBA 06/2012 - 02/2002
4	CarcinogensIBA 05/2011 - 01/2002
3	Biological ProductsIBA 01/2021 - 08/2009
3	Blocking AntibodiesIBA 01/2021 - 06/2003

Therapy/Procedure

60	Therapeutics 01/2022 - 11/2002
51	Immunotherapy 10/2022 - 04/2002
11	Drug Therapy (Chemotherapy) 01/2020 - 01/2006
9	Ligation 01/2020 - 05/2003
5	Radiotherapy 01/2017 - 07/2012